awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26745933-2B4D0AC9-5CF8-461D-AF9F-61B928151A7A
Q26745933-2B4D0AC9-5CF8-461D-AF9F-61B928151A7A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745933-2B4D0AC9-5CF8-461D-AF9F-61B928151A7A
Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
P2860
Q26745933-2B4D0AC9-5CF8-461D-AF9F-61B928151A7A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745933-2B4D0AC9-5CF8-461D-AF9F-61B928151A7A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12f439c6d4370e505f16483692855c73ddbe1ca2
P2860
Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study.